1. Rode HB, Andugulapati SB, Maykalwar SP, Eedara AC, Balasubramaniyan A, DusthackeerVN Azger. 2-Pyridyl amides as inhibitors of drug-resistant tuberculosis. IN202511089316.

2. Rode HB Chopra S, Shinde AU, Maykalwar SP, Maitra R, Saxena D. Quaternary ammonium heterocyclic compound with antibacterial activity. IN202511055004.

3. Rode HB, Bokara KK, Choudhari DJ, Shinde AU, Martin AK, Sardana Y, Muruganandham RD. Compounds with SARS-CoV- 2 inhibition. IN202511044885.

4. Gangarajula S, Chennam R, Kumaraguru T, Rode HB, Maddi SR, Chada RR, Ghosh S. A process for the preparation of Ledipasvir. WO2024/110994A1.

5. Gangarajula S, Chennam R, Kumaraguru T, Rode HB, Maddi SR, Chada R R,  Ghosh S. A process for the preparation of Ledipasvir. IN2023/051091.

6. Rode HB, Andugulapati SB, Maykalwar SP, Shinde AU, Choudhari DJ, Kambhampati V, Balasubramaniyan A, DusthackeerVN Azger. 2-pyridyl amide containing six-membered heterocyclic compounds as antituberculosis agents. IN202611035206.​